Vitrectomy with subretinal tissue plasminogen activator (r-TPA) and intravitreal injection of anti-vascular endothelial growth factor (anti-VEGF) for submacular hemorrhages treatment: Retrospective analysis of 22 cases.

Background: Macular hemorrhages are a severe complication of other retinal pathologies, such as age-related macular degeneration (AMD) or macroaneurysms. Their therapeutic approach is not standardized, and can vary from observation to surgical treatment.

Material And Methods: Retrospective analysis of 22 cases of macular hemorrhage, treated with vitrectomy associated to subretinal rTPA and intravitreal anti-VEGF over a period of 5 years.

[Treatment of retinal re-detachment in eyes with intraocular silicone oil].

Purpose: To describe the standardized surgical technique we used to treat recurrent retinal detachment in eyes that had been previously operated on with silicone oil.

Method: We present 6 cases in which the following surgical steps were carried out as a standardized procedure: 1) silicone oil extraction, 2) partial introduction of perfluorcarbon liquids (PFCL), 3) extraction of epiretinal membranes, 4) endodiathermy, 5) retinotomy, 6) retinectomy, 7) complete filling of the intraocular cavity with PFCL, 8) endophotocoagulation and 9) 5,000 Cs silicone oil injection.

Results: All the patients maintained the reattached retina.